Latest Schedule 13G passive stakes

Morgan Stanley has disclosed beneficial ownership of 5.9% of iQIYI, Inc.'s Class A Ordinary Shares/ADS as of June 30, 2026.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 1,100,072 Class A ordinary shares, representing 5.16% of the outstanding shares, in Hall Chadwick Acquisition Corp.

Farallon Capital Management, L.L.C. and associated entities have reported a beneficial ownership of 9.99% in Protagonist Therapeutics, Inc. as of June 30, 2026.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 1,241,273 Class A ordinary shares, representing 5.25% of the outstanding shares of General Purpose Acquisition Corp.

Farallon Capital Management and associated entities have disclosed beneficial ownership of 9.7% of Minerva Neurosciences' common stock, primarily through convertible preferred stock and warrants.

Glazer Capital, LLC and Paul J. Glazer have disclosed beneficial ownership of 1,800,228 Class A Ordinary Shares, representing 7.63% of the class, in Fifth Era Acquisition Corp I.

Morgan Stanley and its subsidiary report a combined beneficial ownership of 12.8% in Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust.

Morgan Stanley and its subsidiary report a combined beneficial ownership of 12.8% in Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust.

Farallon Capital Management, L.L.C. and affiliated entities have reported beneficial ownership of 8.6% of Lantheus Holdings, Inc. common stock as of June 30, 2026.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 1,199,928 Class A ordinary shares, representing 5.22% of the class, in Roman DBDR Acquisition Corp. II.

Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 9.6% of GRAIL, Inc.'s common stock.

Glazer Capital, LLC, through its managed funds, has reported beneficial ownership of 1,175,932 shares, representing 5.84% of Dynamix Corporation III's Class A ordinary shares.

Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 9.99% of Beam Therapeutics Inc.'s common stock, as of June 30, 2026.

Morgan Stanley has filed a Schedule 13G amendment, reporting a beneficial ownership of Embraer S.A. common stock below the 5% threshold as of June 30, 2026.

Morgan Stanley has filed a Schedule 13G amendment, reporting a beneficial ownership of Embraer S.A. common stock below the 5% threshold as of June 30, 2026.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 4.12% of Drugs Made in America Acquisition Corp.'s ordinary shares.

Farallon Capital Management, L.L.C. and its affiliates have reported beneficial ownership of 595,000 shares, representing 1.3% of Beta Bionics, Inc.'s common stock, as of June 30, 2026.

Glazer Capital, LLC and Paul J. Glazer have filed an amendment to their Schedule 13G, reporting beneficial ownership of 4,927,041 shares of DigitalBridge Group, Inc. Class A Common Stock, representing 2.70% of the class.

Glazer Capital, LLC and its managing member Paul J. Glazer have reported beneficial ownership of 922,196 ordinary shares, representing 6.37% of the class, in Breeze Acquisition Corp. II.

Brueckner Frank Ulrich has filed a Schedule 13G, reporting beneficial ownership of 9.7% of Cheer Holding, Inc.'s Class A Ordinary Shares.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 1,600,072 units, representing 7.77% of Axiom Intelligence Acquisition Corp's Class A Ordinary Shares and Rights.

GIC Private Limited has reported a 5.64% beneficial ownership of Globant S.A.'s common shares as of June 30, 2026, maintaining a substantial institutional presence.

Turning Rock Capital Partners, LP, along with affiliated entities, has disclosed a beneficial ownership of 3.8% of Beasley Broadcast Group Inc.'s Class A Common Stock.

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G amendment, reporting no beneficial ownership of Enhanced Group Inc. (f/k/a A Paradise Acquisition Corp.) Class A Common Stock as of June 30, 2026.

Yuling Luo has reported beneficial ownership of 6.4% of Alamar Biosciences' common stock as of June 30, 2026, including exercisable options and shares held by spouse.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a beneficial ownership of Cryoport, Inc. common stock below the 5% threshold.

Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a beneficial ownership of Cryoport, Inc. common stock below the 5% threshold.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 1,450,876 Class A ordinary shares, representing 5.05% of the outstanding shares, in Alussa Energy Acquisition Corp. II.

Glazer Capital, LLC and its managing member Paul J. Glazer have reported beneficial ownership of 965,704 Class A ordinary shares, representing 5.45% of the outstanding shares, in Apogee Acquisition Corp.

Long Pond Capital, LP, Long Pond Capital GP, LLC, and John Khoury have reported a 0% beneficial ownership in Summit Hotel Properties, Inc., indicating a full divestment.